Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

High Early Death Rate With Excellent Survival Beyond Day 30 in Acute Promyelocytic Leukemia confirmed in unselected patients: Results of a Population-based Registry Study

Autor: Nørgaard, Jan M., Østgård, Lene Sofie Granfeldt, Kjeldsen, Eigil, Holm, Mette S., Andersen, Mette K., Nielsen, Ove J., Kjeldsen, Lars, Kallenbach, Maria, Severinsen, Marianne Tang, Johansen, Preben, Friis, Lone Smidstrup, Weber, Duruta, Kerndrup, Gitte Birk, Preiss, Birgitte Strange, Jensen, Morten K., Dufva, Inge Høgh, Timshel, Susanne, Brown, Peter

Publikováno v: Nørgaard, J M, Østgård, L S G, Kjeldsen, E, Holm, M S, Andersen, M K, Nielsen, O J, Kjeldsen, L, Kallenbach, M, Severinsen, M T, Johansen, P, Friis, L S, Weber, D, Kerndrup, G B, Preiss, B S, Jensen, M K, Dufva, I H, Timshel, S & Brown, P 2012, ' High Early Death Rate With Excellent Survival Beyond Day 30 in Acute Promyelocytic Leukemia confirmed in unselected patients: Results of a Population-based Registry Study ', European Cancer Rehabilitation & Survivorship Symposium 2012, København, Denmark, 17/09/2012-18/09/2012 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3062::b4d5103162dac54da463959c4f623382
https://portal.findresearcher.sdu.dk/da/publications/98d520ee-fd95-4a26-9000-f151e4747564

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura

Autor: Braendstrup, Peter, Bjerrum, Ole W, Nielsen, Ove J, Jensen, Bjarne A, Clausen, Nielsaage T, Hansen, Per Boye, Andersen, Ivan, Schmidt, Kai, Andersen, Torben M, Peterslund, Niels A, Birgens, Henrik S, Plesner, Torben, Pedersen, Bjarne B, Hasselbalch, Hans C

Publikováno v: Braendstrup, P, Bjerrum, O W, Nielsen, O J, Jensen, B A, Clausen, N T, Hansen, P B, Andersen, I, Schmidt, K, Andersen, T M, Peterslund, N A, Birgens, H S, Plesner, T, Pedersen, B B & Hasselbalch, H C 2005, ' Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura. ', American Journal of Hematology, vol. 78, no. 4, pp. 275-80 . https://doi.org/10.1002/ajh.20276

Udgivelsesdato: 2005-Apr Idiopathic thrombocytopenic purpura is an autoimmune disease which involves opsonization of platelets by autoantibodies directed against different surface glycoproteins, leading to their premature destruction by the reticuloe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3062::1aa41db5673e9e593b3f1bba8feb2efd
https://portal.findresearcher.sdu.dk/da/publications/7fab7200-53f8-11dd-b1a1-000ea68e967b

Sustained remission of platelet counts following monoclonal anti-CD20 antibody therapy in two cases of idiopathic autoimmune thrombocytopenia and neutropenia.

Autor: Faurschou, Mikkel, Hasselbalch, Hans C., Nielsen, Ove J.

Publikováno v: European Journal of Haematology; Jun2001, Vol. 66 Issue 6, p408-411, 4p, 1 Chart, 1 Graph

Impaired CD163 Mediated Hemoglobin-Scavenging and Hemolytic Crisis in Patients Treated with CD33 Targeted Chemotherapy (Gemtuzumab Ozogamicin, Mylotarg™).

Autor: Maniecki, Maciej B. ^*, Hasle, Henrik, Friis-Hansen, Lennart ^*, Lausen, Birgitte, Nielsen, Ove J. ^*, Bendix, Knud ^*, Moestrup, Soren K. ^*, Moller, Holger J. ^*

Publikováno v: In Blood 16 November 2007 110(11):3684-3684